Purchase Order 75H70526P00008
- Not listed
- The Indian Health Service awarded a delivery order to Roche Diagnostics Corporation on August 4, 2023, with a ceiling value of $103,435.25 for diagnostic equipment and services at the place of performance in Ogema, Minnesota. This firm fixed-price contract, which is not set-aside designated, represents a child award under a larger contract vehicle and reflects Roche Diagnostics' role as a leading supplier of in vitro diagnostic solutions, laboratory instruments, and associated medical products...
- This is a delivery order awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, under a multi-year Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the Indian Health Service (IHS), a civilian agency of the Department of Health and Human Services. The $105,000.00 firm-fixed-price delivery order has a period of performance from January 1, 2025 to March 31, 2025, with no set-aside...
- The Indian Health Service awarded a $75,681.84 firm fixed-price purchase order to Roche Diagnostics Corporation on January 4, 2024, for a five-year instrument placement agreement that includes reagent and quality control test kits procurement. The contract, which serves the IHS laboratory department facility in Chinle, Arizona, has an ultimate completion date of September 30, 2025, and was awarded without set-aside designation. As a global leader in in vitro diagnostics and laboratory...
- This is a cost-per-test delivery order for $255,406.19 awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, by the Indian Health Service, a civilian agency of the U.S. Department of Health and Human Services. The contract has a completion date of September 24, 2023 and is a firm fixed-price delivery order with no set-aside designation. Roche Diagnostics provides a range of laboratory equipment, reagents, and clinical testing services to...
- Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Department of Health and Human Services Indian Health Service, with a potential value of $41,224.32. The contract has no set-aside designation and runs from June 6, 2019 through February 28, 2024 to provide laboratory supplies for the FY18 Gallup, New Mexico GIMC Laboratory. Roche Diagnostics Corp will deliver critical medical equipment, reagents, test kits and associated consumables to support clinical chemistry,...
- The Indian Health Service awarded a $58.8K delivery order to Roche Diagnostics Corporation for laboratory equipment and diagnostic services at the Tohatchi, New Mexico facility. This firm fixed-price contract, effective April 1, 2020 through March 31, 2021 with ultimate closure on June 30, 2021, was awarded without set-aside designation on March 18, 2020. The delivery order is a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule, which...
- This federal contract award was issued by the Indian Health Service, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $143,353.75 firm-fixed-price delivery order is for cost-per-test analyzers and preventative maintenance services, with a completion date of September 24, 2023. The contract is not set aside and was competed openly. Roche...
- This is a $203,134.39 firm fixed price delivery order awarded by the Indian Health Service, a civilian federal agency, to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products. The contract is for the provision of chemistry reagents and supplies, and is placed under the General Services Administration (GSA) Critical Analyzers, Laboratory (FSS-66-III) schedule contract. There is no set-aside designation for this award. Roche Diagnostics...
- This is a Delivery Order for CLSU COST/PER/TEST, ANALYZERS, AND PM awarded to Roche Diagnostics Corporation by the Indian Health Service, a civilian federal agency. The $465,000.00 Firm Fixed Price contract has an ultimate completion date of December 31, 2024. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical laboratory instruments, reagents, and supplies to various federal agencies through its General Services Administration (GSA) Schedule...
- Roche Diagnostics Corporation was awarded a $52,271.96 firm fixed price delivery order by the Department of Health and Human Services Indian Health Service for COST/PER/TEST. The contract has a period of performance through September 24, 2020 for the IHS, which provides healthcare services to American Indian and Alaska Native communities. No set-aside designation was used for this award to Roche, which will deliver laboratory testing services to the IHS clinic located in Ogema, Minnesota.
The Indian Health Service awarded a purchase order to Roche Diagnostics Corporation for laboratory supplies valued at $22,632.11 under a firm fixed-price contract. This order, issued on January 14, 2026, represents a child action under the parent indefinite delivery contract 75H70519D00022, with performance extending through January 31, 2026. The supplies were invoiced by Roche Lab Supplies for the period September 1 through October 6, 2022, and will be delivered to the Cass Lake, Minnesota location. This award was made through open competition with no set-aside designation. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, is a leading supplier of in vitro diagnostic equipment, reagents, and laboratory instruments to federal healthcare agencies. The company maintains an extensive contracting presence across the Department of Veterans Affairs, Defense Health Agency, and other civilian federal healthcare entities, providing diagnostic solutions including molecular analyzers, histology staining systems, immunochemistry platforms, and point-of-care testing devices. The indefinite delivery contract vehicle supporting this purchase order reflects the Indian Health Service's ongoing relationship with Roche for comprehensive laboratory diagnostic capabilities to support clinical operations at its healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.6k | 1/14/26 |